XSTREQ
Live / Applied — Third extension granted (statement of use) (as of 06 Feb 2026)
What this means for you
Not registered yet, but its 01 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98250652
- Mark type
- Stylized text
- Filed
- 01 Nov 2023
- Published for opposition
- 16 Jul 2024
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
Owner
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 06 Feb 2026 — SOU EXTENSION 3 GRANTED
- 06 Feb 2026 — SOU EXTENSION 3 FILED
- 06 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Aug 2025 — SOU EXTENSION 2 GRANTED
- 07 Aug 2025 — SOU EXTENSION 2 FILED
- 07 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Feb 2025 — SOU EXTENSION 1 GRANTED
- 04 Feb 2025 — SOU EXTENSION 1 FILED
- 04 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jul 2024 — PUBLISHED FOR OPPOSITION
- 16 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED